Insurance Denials for Fluoride Varnish and Well-Child Visits
ResearchPosted on rand.org Oct 17, 2025Published in: JAMA Network Open, Volume 8, No. 10 (October 2025). DOI: 10.1001/jamanetworkopen.2025.37086
ResearchPosted on rand.org Oct 17, 2025Published in: JAMA Network Open, Volume 8, No. 10 (October 2025). DOI: 10.1001/jamanetworkopen.2025.37086
The Patient Protection and Affordable Care Act (ACA) required insurers to cover evidence-based preventive services without patient cost-sharing. Despite this mandate, pediatricians report issues with reimbursement for fluoride varnish—a treatment recommended by the US Preventive Services Task Force in 2014 for children 5 years and younger and reaffirmed in December 2021 for children 4 years and younger. Furthermore, claim denials are a problem more broadly. We used all-payer claims data (APCD) to examine claim denials for fluoride varnish applications and well-child medical visits (WCVs) for Medicaid and private insurers in Massachusetts.
This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.